The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression

Methylglyoxal, a major precursor of advanced glycation end products, is elevated in the plasma of patients with type 2 diabetes mellitus. Islet β-cell function was recently shown to be regulated by N6-methyladenosine (m6A), an RNA modification consisting of methylation at the N6 position of adenosin...

Full description

Bibliographic Details
Main Authors: Yi Cheng, Xin-Ming Yao, Si-Min Zhou, Yue Sun, Xiang-Jian Meng, Yong Wang, Yu-Jie Xing, Shu-Jun Wan, Qiang Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.910868/full
_version_ 1818114615998939136
author Yi Cheng
Xin-Ming Yao
Si-Min Zhou
Yue Sun
Xiang-Jian Meng
Yong Wang
Yu-Jie Xing
Yu-Jie Xing
Shu-Jun Wan
Shu-Jun Wan
Shu-Jun Wan
Qiang Hua
Qiang Hua
author_facet Yi Cheng
Xin-Ming Yao
Si-Min Zhou
Yue Sun
Xiang-Jian Meng
Yong Wang
Yu-Jie Xing
Yu-Jie Xing
Shu-Jun Wan
Shu-Jun Wan
Shu-Jun Wan
Qiang Hua
Qiang Hua
author_sort Yi Cheng
collection DOAJ
description Methylglyoxal, a major precursor of advanced glycation end products, is elevated in the plasma of patients with type 2 diabetes mellitus. Islet β-cell function was recently shown to be regulated by N6-methyladenosine (m6A), an RNA modification consisting of methylation at the N6 position of adenosine. However, the role of m6A methylation modification in methylglyoxal-induced impairment of insulin secretion in pancreatic β cells has not been clarified. In this study, we showed that treatment of two β-cell lines, NIT-1 and β-TC-6, with methylglyoxal reduced m6A RNA content and methyltransferase-like 3 (METTL3) expression levels. We also showed that silencing of METTL3 inhibited glucose-stimulated insulin secretion (GSIS) from NIT-1 cells, whereas upregulation of METTL3 significantly reversed the methylglyoxal-induced decrease in GSIS. The methylglyoxal-induced decreases in m6A RNA levels and METTL3 expression were not altered by knockdown of the receptor for the advanced glycation end product but were further decreased by silencing of glyoxalase 1. Mechanistic investigations revealed that silencing of METTL3 reduced m6A levels, mRNA stability, and the mRNA and protein expression levels of musculoaponeurotic fibrosarcoma oncogene family A (MafA). Overexpression of MafA greatly improved the decrease in GSIS induced by METTL3 silencing; silencing of MafA blocked the reversal of the MG-induced decrease in GSIS caused by METTL3 overexpression. The current study demonstrated that METTL3 ameliorates MG-induced impairment of insulin secretion in pancreatic β cells by regulating MafA.
first_indexed 2024-12-11T03:53:33Z
format Article
id doaj.art-c805ce8e83e647da977b9574bc3c7bed
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-11T03:53:33Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-c805ce8e83e647da977b9574bc3c7bed2022-12-22T01:21:50ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-07-011310.3389/fendo.2022.910868910868The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA ExpressionYi Cheng0Xin-Ming Yao1Si-Min Zhou2Yue Sun3Xiang-Jian Meng4Yong Wang5Yu-Jie Xing6Yu-Jie Xing7Shu-Jun Wan8Shu-Jun Wan9Shu-Jun Wan10Qiang Hua11Qiang Hua12Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaKey Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College, Wuhu, ChinaKey Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College, Wuhu, ChinaCentral Laboratory of Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, ChinaClinical Research Center for Critical Respiratory Medicine of Anhui Province, Wannan Medical College, Wuhu, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, ChinaClinical Research Center for Critical Respiratory Medicine of Anhui Province, Wannan Medical College, Wuhu, ChinaMethylglyoxal, a major precursor of advanced glycation end products, is elevated in the plasma of patients with type 2 diabetes mellitus. Islet β-cell function was recently shown to be regulated by N6-methyladenosine (m6A), an RNA modification consisting of methylation at the N6 position of adenosine. However, the role of m6A methylation modification in methylglyoxal-induced impairment of insulin secretion in pancreatic β cells has not been clarified. In this study, we showed that treatment of two β-cell lines, NIT-1 and β-TC-6, with methylglyoxal reduced m6A RNA content and methyltransferase-like 3 (METTL3) expression levels. We also showed that silencing of METTL3 inhibited glucose-stimulated insulin secretion (GSIS) from NIT-1 cells, whereas upregulation of METTL3 significantly reversed the methylglyoxal-induced decrease in GSIS. The methylglyoxal-induced decreases in m6A RNA levels and METTL3 expression were not altered by knockdown of the receptor for the advanced glycation end product but were further decreased by silencing of glyoxalase 1. Mechanistic investigations revealed that silencing of METTL3 reduced m6A levels, mRNA stability, and the mRNA and protein expression levels of musculoaponeurotic fibrosarcoma oncogene family A (MafA). Overexpression of MafA greatly improved the decrease in GSIS induced by METTL3 silencing; silencing of MafA blocked the reversal of the MG-induced decrease in GSIS caused by METTL3 overexpression. The current study demonstrated that METTL3 ameliorates MG-induced impairment of insulin secretion in pancreatic β cells by regulating MafA.https://www.frontiersin.org/articles/10.3389/fendo.2022.910868/fullMETTL3methylglyoxalN6-methyladenosinepancreatic β cellsinsulin secretion
spellingShingle Yi Cheng
Xin-Ming Yao
Si-Min Zhou
Yue Sun
Xiang-Jian Meng
Yong Wang
Yu-Jie Xing
Yu-Jie Xing
Shu-Jun Wan
Shu-Jun Wan
Shu-Jun Wan
Qiang Hua
Qiang Hua
The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
Frontiers in Endocrinology
METTL3
methylglyoxal
N6-methyladenosine
pancreatic β cells
insulin secretion
title The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
title_full The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
title_fullStr The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
title_full_unstemmed The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
title_short The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression
title_sort m6a methyltransferase mettl3 ameliorates methylglyoxal induced impairment of insulin secretion in pancreatic β cells by regulating mafa expression
topic METTL3
methylglyoxal
N6-methyladenosine
pancreatic β cells
insulin secretion
url https://www.frontiersin.org/articles/10.3389/fendo.2022.910868/full
work_keys_str_mv AT yicheng them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT xinmingyao them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT siminzhou them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yuesun them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT xiangjianmeng them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yongwang them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yujiexing them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yujiexing them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT qianghua them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT qianghua them6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yicheng m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT xinmingyao m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT siminzhou m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yuesun m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT xiangjianmeng m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yongwang m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yujiexing m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT yujiexing m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT shujunwan m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT qianghua m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression
AT qianghua m6amethyltransferasemettl3amelioratesmethylglyoxalinducedimpairmentofinsulinsecretioninpancreaticbcellsbyregulatingmafaexpression